Report Description Table of Contents Market Overview:- The Global Blood Glucose Monitoring Devices Market valuation was at 13.42 billion US dollars in 2020, and the market is predicted to grow at a CAGR of 7.921% from 2021 to 2028. Diabetes incidence is rising at a spiraling rate, coupled with increasing geriatric populations at risk for diabetes, which will drive the market. In addition, new product launches and increased awareness of diabetes preventive care are significantly adding to the market growth. A diabetic condition is when the pancreas cannot produce enough insulin to maintain an average glucose level inside the body. In diabetes treatment, Blood Glucose Monitoring (BGM) Devices are a crucial aid for accurate diagnosis and treatment. A glucose meter measures blood sugar levels, which plays a vital role in diabetic treatment. It is also used to prevent other health conditions, such as neuropathy, retinopathy, and cardiovascular disease. Impact of Covid-19 on the Blood Glucose Monitoring Devices Market:- You will find a wide range of blood glucose monitors in the market with different features and sizes, prices, and testing times. Several countries went on lockdown during the Coronavirus outbreak to control the spread. The lockdown has resulted in changes in the daily routines of diabetic patients, including the way they eat, exercise, and remain sedentary. The abnormal fluctuations in blood glucose levels caused by these have increased the demand for glucose monitoring devices. In recent months, online sales of all self-monitoring devices have shot up dramatically. Moreover, lockdown led to the stockpiling of blood glucose monitors. Report Coverage & Deliverables:- The PDF report provides the following information: Opportunity in the regional market Benchmarking competitiveness Statistics and forecasts for the past and future Revenue shares of the companies Trends and dynamics of the market Market Dynamics With the rapid advancement of technology and early diagnosis of hypo- and hyperglycemia, the BGM devices market will grow. Across the globe, the number of diabetic patients has been increasing rapidly due to rapid lifestyle changes, alcohol consumption, and smoking. Additionally, obesity is one of the leading causes of diabetes. World Health Organization statistics indicated over 650 million obese people in 2016, and the number is expected to grow over the forecasted period (2020 to 2028). However, inadequate reimbursement and high cost associated with the application of BGM devices and product recalls are prominent factors hampering this market's growth. The aging population is driving demand for healthcare products. The number of older people worldwide is set to double in the next three decades, reaching over 1.5 billion in 2050. The size of the elderly population is estimated to increase in all regions between 2019 and 2050. However, the maximum increase (+312 million persons) will occur in Eastern and South-East Asia. Hence the South East Asian countries are poised to have a massive potential for the Blood glucose monitoring devices market. As per the WHO, the world's elderly population is predicted to nearly double from 12% to 22% by 2050. With such immense market potential, the market is highly profitable. Furthermore, The International Diabetes Federation estimates that approximately 424 million people have diabetes, and these numbers will reach 629 million by 2045. Moreover, Increasing government initiatives to spread awareness about diabetes preventionwill also enhance the market growth in the forecasted period. Based on Product Type: Self-Monitoring Blood Glucose Devices (SMBG) will dominate the market over the forecast period:- 68.3% of the total market share was accounted for self-monitoring blood glucose (SMBG) devices due to their comparatively low cost and ease of use. In self-monitoring, individuals use glucose meters to measure their blood sugar levels. The Self-Monitoring Blood Glucose Devices segment is divided into test strips, blood glucose meter, and lancets. A high usage rate and affordability of the test strips segment led to its dominance in 2020. Therefore, in the forecast period, this segment is likely to grow at a healthy CAGR. Growth is anticipated to be fastest in the Continuous Blood Glucose Monitoring Devices segment in the forecast period. The Continous Glucose Monitoring (CGM) device market share is likely to increase rapidly in the forecasted period. People who require frequent monitoring of blood sugar levels use these devices. As continuous and real-time blood sugar readings are provided, Continuous Blood Glucose Monitoring (CBGM) products help analyze glucose levels. The segregation of the segmentare:- Sensor Devices Insulin Pumps Transmitters And Receivers. There is a tiny sensor embedded under the skin which monitors blood glucose levels. In CGM, a wireless transmitter transmits sugar level measurements to a monitor via this sensor. According to the forecast, transmitters and receivers will hold the largest market share during the forecast period, with healthy CAGR growth. Based on Application: Type 2 diabetes will dominate the market over the forecast period:- Most diabetes cases are usually caused by type 2 diabetes, accounting for 89.2% of all cases. A large amount of insulin does not get appropriately used when you have type 2 diabetes. To effectively treat type 2 diabetes, lifestyle factors such as physical activity and nutrition need to be considered. Patients with type 2 diabetes will eventually require oral medications and insulin to maintain proper blood glucose levels. Type 1 diabetes cases can occur in any issue, but it occurs mainly in children and adolescents. Unfortunately, research cannot pinpoint the cause of the disease becausethe body's immune systemmistakenly kills the Insulin-producing (islets, or islets of Langerhans) cells in the pancreas, which usually fights harmful bacteria and viruses. Based on End-User: Hospitals will dominate the market over the forecast period:- As the largest segment, the Hospital segment held a share of 43.62% in 2020. This share is expected to remain strong during the forecast period as hospital infrastructure will improve, and healthcare expenditure will increase. In addition, hospitals charge a higher rate for measuring blood glucose levels than home health care facilities. Hospitals have additional provisions to store and transfer patient information.As the fastest-growing segment, home care is expected to grow fastest during the forecast period. Among the most popular methods of short-term glucose monitoring throughout the world, home-based glucose monitoring was revolutionized by self-monitoring of blood glucose. Self-Monitoring Blood Glucose (SMBG) is an approach where people with or without diabetes can measure their blood sugar levels at their homes. In addition, patients can check how their treatment, such as diet, insulin, exercise, and stress management, is working based on the reading. Based on Regional Assessment: APAC region is driving the market growth at the highest CAGR rate:- Considering the increasing incidence of obesity, unhealthy diet, and physical inactivity, North America commanded the most extensive blood glucose monitoring device market with a market share of 38.7% of the market. According to the Centers for Disease Control and Prevention (CDC), the number of people aged 18 and older with diabetes, as well as those who were undiagnosed, was 30.3 million in 2015. This data represents 9.4% of the entire US population. According to the CDC data, there are 23.1 million diagnosed diabetics in the United States, i.e., 7.2% of the total population. The existence of highly developed technologies, high healthcare expenditure, increased research and development activities, and large concentrations of significant companies have all contributed to the growth of this market. Due to an increase in the geriatric population prone to diabetes, Europe expected to capture a significant market share during the forecast period. In addition, Europe also sees an increase in demand for BGM due to improvements in its healthcare sector.Forecasts indicate that the Asia Pacific will continue to be a lucrative region during the forecast period. The key factor contributing to the regional market's growth is the improvement of healthcare facilities and reimbursement policies in developing economies. For instance, a recent Australian Bureau of Statistics report indicates that more than 5.1% of Australians were diagnosed with diabetes in 2016. Having a large diabetic population and experiencing rapid economic growth, China will lead the APAC region in 2020. In addition, an increase in awareness of diabetes prevention is fuelingthe development of the market. Insights on the top companies and their market share:- The top players expand their business portfolios by launching new products, making acquisitions, improving their existing products and technologies, and engaging in other activities to strengthen their presence. For instance, Roche launched the Accu-Chek Guide blood glucose monitoring device in August 2016. The company designed the device to reach glucose goals with ease; the device offers glucose monitoring throughout the day. Report Attribute Details Forecast Period 2020 - 2028 Market size value in 2020 USD 13.42 Billion Revenue forecast in 2028 USD 24.69 Billion Growth rate CAGR of approximately 7.92% Base year for estimation 2020 Historical data 2015 – 2019 Unit USD Billion, CAGR (2020 - 2028) Segmentation By Type , By Application, By Region By Type Self-Monitoring Blood Glucose Devices (SMBG)(Blood glucose meters, Testing strips, Lancets), Continuous Blood Glucose Monitoring Devices(Sensors, Transmitter and receiver, Insulin pumps). By Application Type 2 diabetes,Type 1 diabetes By Region North America, Europe, Asia Pacific, Australian Bureau of Statistics. Country Scope U.S. , Canada , France, Germany ,U.K. , China , Japan , India , South Korea, Mexico, Brazil ,U.A.E. etc. Company Usability Profiles Medtronic, B. Braun Melsungen, Nipro, Sanofi, Arkray, Abbott Laboratories, F. Hoffmann-La Roche, Ypsomed, Prodigy Diabetes Care, Acon Laboratories, Nova BiomedicalLifescan, Ascensia Diabetes Care, Dexcom. Pricing and purchase options Avail customized purchase options to meet your exact research needs. The globe's leading blood glucose monitor manufacturers include the following: Medtronic B. Braun Melsungen Nipro Sanofi Arkray Abbott Laboratories F. Hoffmann-La Roche Ypsomed Prodigy Diabetes Care Acon Laboratories Nova BiomedicalLifescan Ascensia Diabetes Care Dexcom Frequently Asked Question About This Report Which is a recently approved blood glucose monitoring device? On 21st June 2021, For people 18 years of age and older with diabetes, the US FDA has approved the Eversense Continuous Glucose Monitoring (CGM) system. This device is the first FDA-approved CGM system to include a fully implantable sensor to detect glucose, worn for up to 90 days. What is the present total market value of the blood glucose monitoring devices market report? The Global blood glucose monitoring devices current market size is 13.42 billion in 2020. What is the forecast period covered in the report? The forecast period covered in the report is from 2021 to 2028. What is the projected growth rate of the blood glucose monitoring devices market? The projected growth rate of blood glucose monitoring devices is 7.91% throughout the forecasted period. What was the share of type 2 diabetes patients in the blood glucose monitoring devices market? Patients with type 2 diabetes comprise 89.2% of the blood glucose monitoring device market. Which companies dominate the Blood Glucose Monitoring Devices market? In the market for blood glucose monitoring systems, the significant players are Roche (Switzerland), Abbott (US), LifeScan (US), Medtronic (Ireland), Dexcom (US), Ypsomed (Switzerland), B. Braun (Germany), Ascensia (Switzerland), Nipro (Japan), Sanofi (France), ARKRAY (Japan), Prodigy Diabetes Care (US), ACON Laboratories (US), and Nova Biomedical (US). Which region is estimated to grow at the fastest rate in the Blood Glucose Monitoring Devices Market? The APAC region, due to its market potential, has the highest growth rate in the Blood Glucose Monitoring Devices Market. Which region has the largest share in the Blood Glucose Monitoring Devices Market? North America accounted for the largest share in the Blood Glucose Monitoring Devices Market. N/A Chapter 1. Introduction 1.1 Study Objectives 1.2 Market Definition Table 1 Inclusions and Exclusions 1.3 Study Scope 1.3.1 Markets Covered Figure 01: Blood Glucose Monitoring Devices Market Segmentation 1.3.2 Geographic Scope Figure 02: Blood Glucose Monitoring Devices Market Geography covered 1.3.3 Years Considered 1.4 Stakeholders Chapter 2. Research Methodology 2.1 Data Procurement 2.2 Paid Database 2.2.1 Secondary Data 2.2.1.1 Key Secondary sources 2.2.2 Primary Data 2.2.2.1 Primary sources 2.2.2.2 Key industry insights 2.2.2.3 Primary interviews with experts 2.2.2.4 Key primary respondent list 2.3 Market Size Estimation 2.4 Bottom-Up and Top-Down Approaches 2.4.1 Bottom-Up Approach 2.4.1.1 Approach for arriving at market size by bottom-up analysis Figure 03: Blood Glucose Monitoring Devices Market: Bottom-Up Approach 2.4.2 Top-Down Approach 2.4.2.1 Approach for Capturing Market Size by Top-Down Analysis Figure 04: Blood Glucose Monitoring Devices Market: Top-Down Approach 2.5 Market Breakdown and Data Triangulation Figure 05: Data Triangulation 2.6 Research Methodology 2.7 Risk Assessment Table 2: Risk Assessment Chapter 3. Executive Summary 3.1 Blood Glucose Monitoring Devices Market: Post-Covid-19 Figure 06: Impact of Covid-19 on Blood Glucose Monitoring Devices Market 3.1.1 Actual Scenario Figure 07: Realistic Scenario: Blood Glucose Monitoring Devices Market, 2020–2028 (USD Million) 3.1.2 Pessimistic Scenario Figure 08: Pessimistic Scenario: Blood Glucose Monitoring Devices Market, 2020–2028 (USD Million) 3.1.3 Optimistic Scenario Figure 09: Optimistic Scenario: Blood Glucose Monitoring Devices Market, 2020–2028(USD Million) 3.1.4 Market Summary Figure 10: Self-Monitoring Blood Glucose Devices (SMBG) to Witness Highest CAGR in Blood Glucose Monitoring Devices Market, By Product Type, During Forecast Period Figure 11: Hospital segment to Witness Higher CAGR in Blood Glucose Monitoring Devices Market for End-User Segment during Forecast Period Figure 12: type 2 diabetes for Application to Register Highest CAGR in Blood Glucose Monitoring Devices Market during Forecast Period Figure 13: North America to Account for Largest Share of Global Blood Glucose Monitoring Devices Market In 2020 Chapter 4. Market Definitions 4.1 Market Segmentation Figure 14: Blood Glucose Monitoring Devices Market Segmentation Chapter 5. Industry Outlook 5.1 Market Snapshot 5.2 Global Blood Glucose Monitoring Devices Market 5.2.1 Global Blood Glucose Monitoring Devices market, 2020 – 2028 (USD Million) 5.3 Regional Segment Analysis 5.3.1 Global Blood Glucose Monitoring Devices market, by region, 2020 - 2028 (USD Million) 5.4 Product Type Segment Analysis 5.4.1 Global Blood Glucose Monitoring Devices market, by Product Type, 2020 - 2028 (USD Million) 5.5 End-User Analysis 5.5.1 Global Blood Glucose Monitoring Devices market, by End-User, 2020 - 2028 (USD Million) 5.6 Application Segment Analysis 5.6.1 Global Blood Glucose Monitoring Devices market, by Application, 2020 - 2028 (USD Million) 5.7 By Usage Business Analysis 5.8 Value Chain Analysis 5.9 Market Variable Analysis 5.9.1 Market Drivers Analysis 5.9.2 Market Restraints Analysis 5.10 Business Environment Analysis Tool 5.10.1 Blood Glucose Monitoring Devices market PEST analysis 5.10.2 Blood Glucose Monitoring Devices market Porter’s analysis 5.11 Penetration & Growth Prospect Mapping Chapter 6. Market Overview 6.1 Introduction 6.2 Market Dynamics Figure 15 Blood Glucose Monitoring Devices Market: Drivers, Restraints, Opportunities, and Challenges 6.2.1 Drivers Figure 16 Blood Glucose Monitoring Devices Market Drivers and Their Impact 6.2.2 Restraints Figure 17 Blood Glucose Monitoring Devices Market Restraints and Their Impact 6.2.3 Opportunities Figure 18 Blood Glucose Monitoring Devices Market Opportunities and Their Impact 6.2.4 Challenges Figure 19 Blood Glucose Monitoring Devices Market Challenges and Their Impact 6.3 Impact of Covid-19 on Blood Glucose Monitoring Devices Market 6.4 Value Chain Analysis Figure 20 Value Chain Analysis: Blood Glucose Monitoring Devices Market 6.5 Ecosystem Figure 21 Blood Glucose Monitoring Devices Market: Ecosystem Table 3 Blood Glucose Monitoring Devices Market: Ecosystem Figure 22 Revenue Shift in Blood Glucose Monitoring Devices Market 6.6 Patent Analysis Table 4 Number of Patents Registered in Blood Glucose Monitoring Devices Market in USA in Last 9 Years Figure 23 Top 13 Companies with Highest No. of Patents in Last 9 Years Figure 24 No of Patents Granted Per Year, 2019–2020 Table 5 List of Global Patents in Blood Glucose Monitoring Devices Market 6.7 Trade Analysis Figure 25 Import Data for Self-Monitoring Blood Glucose Devices (SMBG), By Country, 2016–2020 (USD Thousand) Table 6 Import Data for Continuous Blood Glucose Monitoring Devices, By Country, 2016–2020 (USD Thousand) Figure 26 Export Data for Self-Monitoring Blood Glucose Devices (SMBG), By Country, 2016–2020 (USD Thousand) Table 7 Export Data for Continuous Blood Glucose Monitoring Devices, By Country, 2016–2020 (USD Thousand) 6.8 Tariff Analysis 6.9 Case Study Analysis 6.10 Porter’s Five Forces Analysis Table 8 Blood Glucose Monitoring Devices Market: Porter’s Five Forces Analysis, 2020 6.10.1 Threat of New Entrants 6.10.2 Threat of Substitutes 6.10.3 Bargaining Power of Buyers 6.10.4 Bargaining Power of Suppliers 6.10.5 Degree of Competition 6.11 Technology Analysis 6.11.1 Trends in Technology (2014-2020) 6.11.2 Trends in Technology (2021-2028) Table 9 Key Regulations: Blood Glucose Monitoring Devices Market 6.12 Pricing Analysis 6.12.1 Average Price Trend Analysis (By region, By Countries) Chapter 7. Competitive & Vendor Landscape 7.1 Company Market Share Analysis Table 10: Key Players market share Figure 27: Key players market share of companies 7.2 Manufacturers Blood Glucose Monitoring Devices Manufacturing Sites, Area Served, Product Type Product Type 7.3 Blood Glucose Monitoring Devices Market Competitive Situation and Trends 7.4 Manufacturers Mergers & Acquisitions, Expansion Plans Chapter 8. Global Blood Glucose Monitoring Devices Market: Product Type Segment Analysis 8.1 Introduction 8.2 Sales Volume & Revenue Analysis (2020-2028) Table 11 Blood Glucose Monitoring Devices Market, By Product Type, 2021–2028 (USD Million) Figure 28 Blood Glucose Monitoring Devices Market, By Product Type Figure 29 Self-Monitoring Blood Glucose Devices (SMBG) Segment to Register Highest CAGR in Blood Glucose Monitoring Devices Market During Forecast Period 8.3 Self-Monitoring Blood Glucose Devices (SMBG) 8.3.1 Self-Monitoring Blood Glucose Devices (SMBG) market, 2020 - 2028 (USD Million) 8.3.1.1 Blood glucose meters market, 2020 - 2028 (USD Million) 8.3.1.2 Testing strips market, 2020 - 2028 (USD Million) 8.3.1.3 Lancets market, 2020 - 2028 (USD Million) Figure 30: Self-Monitoring Blood Glucose Devices (SMBG) market, 2020 - 2028 (USD Million) 8.4 Continuous Blood Glucose Monitoring Devices 8.4.1 Continuous Blood Glucose Monitoring Devices market, 2020 - 2028 (USD Million) 8.4.1.1 Sensors market, 2020 - 2028 (USD Million) 8.4.1.2 Transmitter and receiver market, 2020 - 2028 (USD Million) 8.4.1.3 Insulin pumps market, 2020 - 2028 (USD Million) Figure 31: Continuous Blood Glucose Monitoring Devices market, 2020 - 2028 (USD Million) Chapter 9. Global Blood Glucose Monitoring Devices Market: End-User Segment Analysis 9.1 Introduction 9.2 Sales Volume & Revenue Analysis (2020-2028) Table 12: Blood Glucose Monitoring Devices Market, By End-User, 2021–2028 (USD Million) Figure 32 Blood Glucose Monitoring Devices Market, By End-User, 2021–2028 (USD Million) Figure 33: Hospitals to Register Highest CAGR in Blood Glucose Monitoring Devices Market during Forecast Period 9.3 Hospitals 9.3.1 Hospitals market, 2020 - 2028 (USD Million) Figure 34: Hospitals market, 2020 - 2028 (USD Million) 9.4 Home Care 9.4.1 Home Care market, 2020 - 2028 (USD Million) Figure 35: Home Care market, 2020 - 2028 (USD Million) 9.5 Diagnostic centers 9.5.1 Diagnostic centers market, 2020 - 2028 (USD Million) Figure 36: Diagnostic centers market, 2020 - 2028 (USD Million) Chapter 10. Global Blood Glucose Monitoring Devices Market: Applications Segment Analysis 10.1 Introduction 10.2 Sales Volume & Revenue Analysis (2020-2028) Table 13: Blood Glucose Monitoring Devices Market, By Application, 2021–2028 (USD Million) Figure 37: Blood Glucose Monitoring Devices Market, By Application, 2021–2028 (USD Million) Figure 38: type 2 diabetes Segment to Register Highest CAGR in Blood Glucose Monitoring Devices Market during Forecast Period 10.3 Type 2 diabetes 10.3.1 Type 2 diabetes market, 2020 - 2028 (USD Million) Figure 39: Type 2 diabetes market, 2020 - 2028 (USD Million) 10.4 Type 1 diabetes 10.4.1 Type 1 diabetes market, 2020 - 2028 (USD Million) Figure 40: Type 1 diabetes market, 2020 - 2028 (USD Million) Chapter 11. Global Blood Glucose Monitoring Devices Market: Regional Outlook 11.1 North America Figure 41: North America Blood Glucose Monitoring Devices Market, By Revenue Forecast (2020-2028) 11.1.1 North America Blood Glucose Monitoring Devices market, by country, 2020 - 2028 (USD Million) Table 14: North America Blood Glucose Monitoring Devices Market, by Country, 2020-2028 Figure 42: North America Blood Glucose Monitoring Devices Market 11.1.2 North America Blood Glucose Monitoring Devices market, by Product Type, 2020 - 2028 (USD Million) Table15: North America Blood Glucose Monitoring Devices market, by Product Type, 2020 - 2028 (USD Million) Figure 43: North America Blood Glucose Monitoring Devices market, by Product Type, 2020 - 2028 (USD Million) 11.1.3 North America Blood Glucose Monitoring Devices market, by End-User, 2020 - 2028 (USD Million) Table 16: North America Blood Glucose Monitoring Devices market, by End-User, 2020 - 2028 (USD Million) Figure 44: North America Blood Glucose Monitoring Devices market, by End-User, 2020 - 2028 (USD Million) 11.1.4 North America Blood Glucose Monitoring Devices market, by Application, 2020 - 2028 (USD Million) Table 17: North America Blood Glucose Monitoring Devices market, by Application, 2020 - 2028 (USD Million) Figure 45: North America Blood Glucose Monitoring Devices market, by Application, 2020 - 2028 (USD Million) 11.1.5 U.S. 11.1.5.1 U.S. Blood Glucose Monitoring Devices market, by Product Type, 2020 - 2028 (USD Million) Figure 46: U.S. Blood Glucose Monitoring Devices market, by Product Type, 2020 - 2028 (USD Million) 11.1.5.2 U.S. Blood Glucose Monitoring Devices market, by End-User, 2020 - 2028 (USD Million) Figure 47: U.S. Blood Glucose Monitoring Devices market, by End-User, 2020 - 2028 (USD Million) 11.1.5.3 U.S. Blood Glucose Monitoring Devices market, by Application, 2020 - 2028 (USD Million) Figure 48: U.S. Blood Glucose Monitoring Devices market, by Application, 2020 - 2028 (USD Million) 11.1.6 Canada 11.1.6.1 Canada Blood Glucose Monitoring Devices market, by Product Type, 2020 - 2028 (USD Million) Figure 49: Canada Blood Glucose Monitoring Devices market, by Product Type, 2020 - 2028 (USD Million) 11.1.6.2 Canada Blood Glucose Monitoring Devices market, by End-User, 2020 - 2028 (USD Million) Figure 50: Canada Blood Glucose Monitoring Devices market, by End-User, 2020 - 2028 (USD Million) 11.1.6.3 Canada Blood Glucose Monitoring Devices market, by Application, 2020 - 2028 (USD Million) Figure 51: Canada Blood Glucose Monitoring Devices market, by End-User, 2020 - 2028 (USD Million) 11.1.6.4 Canada Blood Glucose Monitoring Devices market, by Application, 2020 - 2028 (USD Million) Figure 52: Canada Blood Glucose Monitoring Devices market, by End-User, 2020 - 2028 (USD Million) 11.2 Europe Figure 53: Europe Blood Glucose Monitoring Devices Market, By Revenue Forecast (2020-2028) 11.2.1 Europe Blood Glucose Monitoring Devices market, by country, 2020 - 2028 (USD Million) Table 18: Europe Blood Glucose Monitoring Devices market, by country, 2020 - 2028 (USD Million) Figure 54: Europe Blood Glucose Monitoring Devices market, by country, 2020 - 2028 (USD Million) 11.2.2 Europe Blood Glucose Monitoring Devices market, by Product Type, 2020 - 2028 (USD Million) Table 19: Europe Blood Glucose Monitoring Devices market, by Product Type, 2020 - 2028 (USD Million) Figure 55: Europe Blood Glucose Monitoring Devices market, by Product Type, 2020 - 2028 (USD Million) 11.2.3 Europe Blood Glucose Monitoring Devices market, by End-User, 2020 - 2028 (USD Million) Table 20: Europe Blood Glucose Monitoring Devices market, by End-User, 2020 - 2028 (USD Million) Figure 56: Europe Blood Glucose Monitoring Devices market, by End-User, 2020 - 2028 (USD Million) 11.2.4 Europe Blood Glucose Monitoring Devices market, by Application, 2020 - 2028 (USD Million) Table 21: Europe Blood Glucose Monitoring Devices market, by Application, 2020 - 2028 (USD Million) Figure 57: Europe Blood Glucose Monitoring Devices market, by Application, 2020 - 2028 (USD Million) 11.2.5 U.K. 11.2.5.1 U.K. Blood Glucose Monitoring Devices market, by Product Type, 2020 - 2028 (USD Million) Figure 58: U.K. Blood Glucose Monitoring Devices market, by Product Type, 2020 - 2028 (USD Million) 11.2.5.2 U.K. Blood Glucose Monitoring Devices market, by End-User, 2020 - 2028 (USD Million) Figure 59: U.K. Blood Glucose Monitoring Devices market, by End-User, 2020 - 2028 (USD Million) 11.2.5.3 U.K. Blood Glucose Monitoring Devices market, by Application, 2020 - 2028 (USD Million) Figure 60: U.K. Blood Glucose Monitoring Devices market, by Application, 2020 - 2028 (USD Million) 11.2.6 Germany 11.2.6.1 Germany Blood Glucose Monitoring Devices market, by Product Type, 2020 - 2028 (USD Million) Figure 61: Germany Blood Glucose Monitoring Devices market, by Product Type, 2020 - 2028 (USD Million) 11.2.6.2 Germany Blood Glucose Monitoring Devices market, by End-User, 2020 - 2028 (USD Million) Figure 62: Germany Blood Glucose Monitoring Devices market, by End-User, 2020 - 2028 (USD Million) 11.2.6.3 Germany Blood Glucose Monitoring Devices market, by Application, 2020 - 2028 (USD Million) Figure 63: Germany Blood Glucose Monitoring Devices market, by Application, 2020 - 2028 (USD Million) 11.2.7 France 11.2.7.1 France Blood Glucose Monitoring Devices market, by Product Type, 2020 - 2028 (USD Million) Figure 64: France Blood Glucose Monitoring Devices market, by Product Type, 2020 - 2028 (USD Million) 11.2.7.2 France Blood Glucose Monitoring Devices market, by End-User, 2020 - 2028 (USD Million) Figure 65: France Blood Glucose Monitoring Devices market, by End-User, 2020 - 2028 (USD Million) 11.2.7.3 France Blood Glucose Monitoring Devices market, by Application, 2020 - 2028 (USD Million) Figure 66: France Blood Glucose Monitoring Devices market, by Application, 2020 - 2028 (USD Million 11.2.8 Rest of Europe 11.2.8.1 Rest of Europe Blood Glucose Monitoring Devices market, by Product Type, 2020 - 2028 (USD Million) Figure 67: Rest of Europe Blood Glucose Monitoring Devices market, by Product Type, 2020 - 2028 (USD Million) 11.2.8.2 Rest of Europe Blood Glucose Monitoring Devices market, by End-User, 2020 - 2028 (USD Million) Figure 68: Rest of Europe Blood Glucose Monitoring Devices market, by End-User, 2020 - 2028 (USD Million) 11.2.8.3 Rest of Europe Blood Glucose Monitoring Devices market, by Application, 2020 - 2028 (USD Million) Figure 69: Rest of Europe Blood Glucose Monitoring Devices market, by Application, 2020 - 2028 (USD Million) 11.3 Asia Pacific Figure 70: Asia Pacific Blood Glucose Monitoring Devices Market, By Revenue Forecast (2020-2028) 11.3.1 Asia Pacific Blood Glucose Monitoring Devices market, by country, 2020 - 2028 (USD Million) Table 22: Asia Pacific Blood Glucose Monitoring Devices market, by country, 2020 - 2028 (USD Million) Figure 71: Asia Pacific Blood Glucose Monitoring Devices market, by country, 2020 - 2028 (USD Million) 11.3.2 Asia Pacific Blood Glucose Monitoring Devices market, by Product Type, 2020 - 2028 (USD Million) Table 23: Asia Pacific Blood Glucose Monitoring Devices market, by Product Type, 2020 - 2028 (USD Million) Figure 72: Asia Pacific Blood Glucose Monitoring Devices market, by Product Type, 2020 - 2028 (USD Million) 11.3.3 Asia Pacific Blood Glucose Monitoring Devices market, by End-User, 2020 - 2028 (USD Million) Table 24: Asia Pacific Blood Glucose Monitoring Devices market, by End-User, 2020 - 2028 (USD Million) Figure 73 Asia Pacific Blood Glucose Monitoring Devices market, by End-User, 2020 - 2028 (USD Million) 11.3.4 Asia Pacific Blood Glucose Monitoring Devices market, by Application, 2020 - 2028 (USD Million) Table 25: Asia Pacific Blood Glucose Monitoring Devices market, by Application, 2020 - 2028 (USD Million) Figure 74: Asia Pacific Blood Glucose Monitoring Devices market, by Application, 2020 - 2028 (USD Million) 11.3.5 China 11.3.5.1 China Blood Glucose Monitoring Devices market, by Product Type, 2020 - 2028 (USD Million) Figure 76: China Blood Glucose Monitoring Devices market, by Product Type, 2020 - 2028 (USD Million) 11.3.5.2 China Blood Glucose Monitoring Devices market, by End-User, 2020 - 2028 (USD Million) Figure 77: China Blood Glucose Monitoring Devices market, by End-User, 2020 - 2028 (USD Million) 11.3.5.3 China Blood Glucose Monitoring Devices market, by Application, 2020 - 2028 (USD Million) Figure 78: China Blood Glucose Monitoring Devices market, by Application, 2020 - 2028 (USD Million) 11.3.6 India 11.3.6.1 India Blood Glucose Monitoring Devices market, by Product Type, 2020 - 2028 (USD Million) Figure 79: India Blood Glucose Monitoring Devices market, by Product Type, 2020 - 2028 (USD Million) 11.3.6.2 India Blood Glucose Monitoring Devices market, by End-User, 2020 - 2028 (USD Million) Figure 80: India Blood Glucose Monitoring Devices market, by End-User, 2020 - 2028 (USD Million) 11.3.6.3 India Blood Glucose Monitoring Devices market, by Application, 2020 - 2028 (USD Million) Figure 81: India Blood Glucose Monitoring Devices market, by Application, 2020 - 2028 (USD Million) 11.3.7 Japan 11.3.7.1 Japan Blood Glucose Monitoring Devices market, by Product Type, 2020 - 2028 (USD Million) Figure 82: Japan Blood Glucose Monitoring Devices market, by Product Type, 2020 - 2028 (USD Million) 11.3.7.2 Japan Blood Glucose Monitoring Devices market, by End-User, 2020 - 2028 (USD Million) Figure 83: Japan Blood Glucose Monitoring Devices market, by End-User, 2020 - 2028 (USD Million) 12.3.7.3 Japan Blood Glucose Monitoring Devices market, by Application, 2020 - 2028 (USD Million) Figure 84: Japan Blood Glucose Monitoring Devices market, by Application, 2020 - 2028 (USD Million) 11.3.8 South Korea 11.3.8.1 South Korea Blood Glucose Monitoring Devices market, by Product Type, 2020 - 2028 (USD Million) Figure 85: South Korea Blood Glucose Monitoring Devices market, by Product Type, 2020 - 2028 (USD Million) 11.3.8.2 South Korea Blood Glucose Monitoring Devices market, by End-User, 2020 - 2028 (USD Million) Figure 86: South Korea Blood Glucose Monitoring Devices market, by End-User, 2020 - 2028 (USD Million) 12.3.8.3 South Korea Blood Glucose Monitoring Devices market, by Application, 2020 - 2028 (USD Million) Figure 87: South Korea Blood Glucose Monitoring Devices market, by Application, 2020 - 2028 (USD Million) 11.3.9 Rest of APAC 11.3.9.1 Rest of APAC Blood Glucose Monitoring Devices market, by Product Type, 2020 - 2028 (USD Million) Figure 88 Rest of APAC Blood Glucose Monitoring Devices market, by Product Type, 2020 - 2028 (USD Million) 11.3.9.2 Rest of APAC Blood Glucose Monitoring Devices market, by End-User, 2020 - 2028 (USD Million) Figure 89: Rest of APAC Blood Glucose Monitoring Devices market, by End-User, 2020 - 2028 (USD Million) 11.3.9.3 Rest of APAC Blood Glucose Monitoring Devices market, by Application, 2020 - 2028 (USD Million) Figure 90: Rest of APAC Blood Glucose Monitoring Devices market, by Application, 2020 - 2028 (USD Million) 11.4 Latin America Figure 91: Latin America Blood Glucose Monitoring Devices Market, By Revenue Forecast (2020-2028) 11.4.1 Latin America Blood Glucose Monitoring Devices market, by country, 2020 - 2028 (USD Million) Table 26: Latin America Blood Glucose Monitoring Devices market, by country, 2020 - 2028 (USD Million) Figure 92: Latin America Blood Glucose Monitoring Devices market, by country, 2020 - 2028 (USD Million) 11.4.2 Latin America Blood Glucose Monitoring Devices market, by Product Type, 2020 - 2028 (USD Million) Table 27: Latin America Blood Glucose Monitoring Devices market, by Product Type, 2020 - 2028 (USD Million) Figure 93: Latin America Blood Glucose Monitoring Devices market, by Product Type, 2020 - 2028 (USD Million) 11.4.3 Latin America Blood Glucose Monitoring Devices market, by End-User, 2020 - 2028 (USD Million) Table 28: Latin America Blood Glucose Monitoring Devices market, by End-User, 2020 - 2028 (USD Million) Figure 94: Latin America Blood Glucose Monitoring Devices market, by End-User, 2020 - 2028 (USD Million) 11.4.4 Latin America Blood Glucose Monitoring Devices market, by Application, 2020 - 2028 (USD Million) Table 29: Latin America Blood Glucose Monitoring Devices market, by Application, 2020 - 2028 (USD Million) Figure 95: Latin America Blood Glucose Monitoring Devices market, by Application, 2020 - 2028 (USD Million) 11.4.5 Brazil 11.4.5.1 Brazil Blood Glucose Monitoring Devices market, by Product Type, 2020 - 2028 (USD Million) Figure 96: Brazil Blood Glucose Monitoring Devices market, by Product Type, 2020 - 2028 (USD Million) 11.4.5.2 Brazil Blood Glucose Monitoring Devices market, by End-User, 2020 - 2028 (USD Million) Figure 97: Brazil Blood Glucose Monitoring Devices market, by End-User, 2020 - 2028 (USD Million) 11.4.5.3 Brazil Blood Glucose Monitoring Devices market, by Application, 2020 - 2028 (USD Million) Figure 98: Brazil Blood Glucose Monitoring Devices market, by Application, 2020 - 2028 (USD Million) 11.4.6 Mexico 11.4.6.1 Mexico Blood Glucose Monitoring Devices market, by Product Type, 2020 - 2028 (USD Million) Figure 99: Mexico Blood Glucose Monitoring Devices market, by Product Type, 2020 - 2028 (USD Million) 11.4.6 2 Mexico Blood Glucose Monitoring Devices market, by End-User, 2020 - 2028 (USD Million) Figure 101: Mexico Blood Glucose Monitoring Devices market, by End-User, 2020 - 2028 (USD Million) 11.4.6.3 Mexico Blood Glucose Monitoring Devices market, by Application, 2020 - 2028 (USD Million) Figure 102: Mexico Blood Glucose Monitoring Devices market, by Application, 2020 - 2028 (USD Million) 11.4.7 Rest of the Latin America 11.4.7.1 Rest of the Latin America Blood Glucose Monitoring Devices market, by Product Type, 2020 - 2028 (USD Million) Figure 103: Rest of the Latin America Blood Glucose Monitoring Devices market, by Product Type, 2020 - 2028 (USD Million) 11.4.7.2 Rest of the Latin America Blood Glucose Monitoring Devices market, by End-User, 2020 - 2028 (USD Million) Figure 104: Rest of the Latin America Blood Glucose Monitoring Devices market, by End-User, 2020 - 2028 (USD Million) 11.4.7.3 Rest of the Latin America Blood Glucose Monitoring Devices market, by Application, 2020 - 2028 (USD Million) Figure 105: Rest of the Latin America Blood Glucose Monitoring Devices market, by Application, 2020 - 2028 (USD Million) 11.5 MEA Figure 106: MEA Blood Glucose Monitoring Devices Market, By Revenue Forecast (2020-2028) 11.5.1 MEA Blood Glucose Monitoring Devices market, by Product Type, 2020 - 2028 (USD Million) Figure 107: MEA Blood Glucose Monitoring Devices market, by Product Type, 2020 - 2028 (USD Million) 11.5.2 MEA Blood Glucose Monitoring Devices market, by End-User, 2020 - 2028 (USD Million) Figure 108: MEA Blood Glucose Monitoring Devices market, by End-User, 2020 - 2028 (USD Million) 11.5.3 MEA Blood Glucose Monitoring Devices market, by Application, 2020 - 2028 (USD Million) Figure 109: MEA Blood Glucose Monitoring Devices market, by Application, 2020 - 2028 (USD Million) Chapter 12. Competitive Landscape 12.1 Medtronic. 12.1.1 Company overview 12.1.2 Financial performance 12.1.3 Product Type Portfolio Analysis 12.1.4 Business Strategy & Recent Development 12.2 B. Braun Melsungen. 12.2 .1 Company overview 12.2 .2 Financial performance 12.2 .3 Product Type Portfolio Analysis 12.2 .4 Business Strategy & Recent Development 12.3 Nipro. 12.3.1 Company overview 12.3.2 Financial performance 12.3.3 Product Type Portfolio Analysis 12.3.4 Business Strategy & Recent Development 12.4 Sanofi. 12.4.1 Company overview 12.4.2 Financial performance 12.4.3 Product Type Portfolio Analysis 12.4.4 Business Strategy & Recent Development 12.5 Arkray. 12.5.1 Company overview 12.5.2 Financial performance 12.5.3 Product Type Portfolio Analysis 12.5.4 Business Strategy & Recent Development 12.6 Abbott Laboratories. 12.6.1 Company overview 12.6.2 Financial performance 12.6.3 Product Type Portfolio Analysis 12.6.4 Business Strategy & Recent Development 12.7 F. Hoffmann-La Roche. 12.7.1 Company overview 12.7.2 Financial performance 12.7.3 Product Type Portfolio Analysis 12.7.4 Business Strategy & Recent Development 12.8 Ypsomed. 12.8.1 Company overview 12.8.2 Financial performance 12.8.3 Product Type Portfolio Analysis 12.8.4 Business Strategy & Recent Development 12.9 Prodigy Diabetes Care. 12.9.1 Company overview 12.9.2 Financial performance 12.9.3 Product Type Portfolio Analysis 12.9.4 Business Strategy & Recent Development 12.10 Acon Laboratories. 12.10.1 Company overview 12.10.2 Financial performance 12.10.3 Product Type Portfolio Analysis 12.10.4 Business Strategy & Recent Development 12.11 Nova BiomedicalLifescan. 12.11.1 Company overview 12.11.2 Financial performance 12.11.3 Product Type Portfolio Analysis 12.11.4 Business Strategy & Recent Development 12.12 Ascensia Diabetes Care. 12.12.1 Company overview 12.12.2 Financial performance 12.12.3 Product Type Portfolio Analysis 12.12.4 Business Strategy & Recent Development 12.13 Dexcom. 12.13.1 Company overview 12.13.2 Financial performance 12.13.3 Product Type Portfolio Analysis 12.13.4 Business Strategy & Recent Development